Pharmacies Industry Stat

Of the top 2,000 public companies in the world, 41 pharmaceutical companies are part of the list and the United States alone has 13 companies. The biggest drug companies of 2014 are led by Pfizer, followed by Novartis, with a combined total net profit of 97.8 billion.

Global 2000 Rank Company Country Sales Profits Assets Market Value
45 Pfizer United States $52.7 B $22 B $172.1 B $203.9 B
54 Novartis Switzerland $57.9 B $9.2 B $126.3 B $227.4 B
87 Sanofi France $43.7 B $4.9 B $132.4 B $137.1 B
90 Roche Holding Switzerland $50.5 B $12 B $69.9 B $253.7 B
99 Merck & Co United States $44.1 B $4.4 B $105.6 B $165.8 B
116 GlaxoSmithKline United Kingdom $41.4 B $8.5 B $69.7 B $128.8 B
183 AstraZeneca United Kingdom $25.7 B $2.6 B $55.9 B $82.3 B
219 Eli Lilly & Co United States $23.1 B $4.7 B $35.2 B $65.9 B
229 Abbott Laboratories United States $21.8 B $2.6 B $43 B $59.4 B
243 McKesson United States $130.1 B $1.2 B $36.5 B $40.5 B
254 AbbVie United States $18.8 B $4.1 B $29.2 B $82.8 B
257 Bristol-Myers Squibb United States $16.4 B $2.6 B $38.6 B $85.9 B
294 Teva Pharmaceutical Inds Israel $20.3 B $1.3 B $47.5 B $44.6 B
348 Takeda Pharmaceutical Japan $17 B $1.1 B $42.1 B $37 B
372 Merck KGaA Germany $14.7 B $1.6 B $28.7 B $36.3 B
399 Novo Nordisk Denmark $14.9 B $4.5 B $13 B $119.6 B
526 Cardinal Health United States $96.7 B $0.4 B $25 B $23.9 B
527 Otsuka Holding Japan $14.4 B $1.8 B $17.9 B $16.1 B
615 Astellas Pharma Japan $11.7 B $0.8 B $14.9 B $26.1 B
674 AmerisourceBergen United States $96.1 B $0.3 B $19.8 B $15.1 B
707 Daiichi Sankyo Japan $10.9 B $0.9 B $17.3 B $11.6 B
753 Allergan United States $6.3 B $1.3 B $10.6 B $36.9 B
816 Mylan United States $7 B $0.6 B $15.2 B $18.3 B
858 Actavis Ireland $8.7 B $-0.8 B $22.7 B $36.5 B
903 Sinopharm Group China $27.1 B $0.4 B $17.4 B $7.1 B
921 Valeant Pharmaceuticals Canada $5.8 B $-0.9 B $28 B $44.6 B
1041 Shire Ireland $5 B $0.7 B $8.3 B $29 B
1275 Eisai Japan $6 B $0.4 B $9.3 B $10.8 B
1293 Sun Pharma Industries India $2.1 B $0.5 B $4.1 B $19.9 B
1330 Zoetis United States $4.6 B $0.5 B $6.6 B $14.7 B
1332 Medipal Holdings Japan $29.5 B $0.2 B $13.4 B $3.6 B
1383 UCB Belgium $4.5 B $0.3 B $13.7 B $15.3 B
1407 Perrigo Ireland $3.8 B $0.3 B $13.7 B $20.8 B
1434 Alfresa Holdings Japan $25.2 B $0.2 B $11.6 B $3.8 B
1526 Actelion Switzerland $1.9 B $0.5 B $3.4 B $10.9 B
1534 Suzuken Japan $20 B $0.2 B $10.3 B $3.5 B
1595 Forest Laboratories United States $3.4 B $0.2 B $9.1 B $25.3 B
1608 Aspen Pharmacare Holdings South Africa $2.3 B $0.4 B $7.7 B $12.1 B
1684 Shionogi & Co. Japan $3 B $0.8 B $5.9 B $6.1 B
1807 Yunnan Baiyao Group China $2.6 B $0.4 B $2.1 B $9.2 B
1955 Toho Holdings Japan $12.1 B $0.1 B $5.9 B $1.6 B

May 2014 forbes.com 2014

Pharmaceuticals is a high profit margin business. The cost of XANAX for example is $0.24, but the consumer price can go up to $136.79, that is a markup of 569,958%.

In the United States, there is no ceiling price prescription, and the price is protected by 20 year patent laws. Until the patent ends, generics that are often 80% cheaper, are not allowed to enter the market.

Researchers found that Big Pharma spends twice more money on Advertisements than they do on R&D. Big Pharma rarely conducts research themselves, they prefer to fund research done by universities and biotech companies. To create a wider market, Big Pharma often exaggerates a disease’s condition, and some companies even hire doctors to help market their drugs.

Sixteen years ago, Professor Irving Weissman discovered a treatment that could cure diabetes and breast cancer, but Big Pharma wasn’t interested because ongoing treatment such as insulin, testing strips, and meters are more profitable.

big-farma-stat